Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 6:00 PM ET

Date/Time Source News Release
10/01/2021 07:02 AM EDT ACCESSWIRE enVVeno Medical Corporation Successfully Completes Rebranding
09/24/2021 09:00 AM EDT ACCESSWIRE Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann
09/21/2021 04:00 PM EDT ACCESSWIRE Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs
09/15/2021 08:05 AM EDT ACCESSWIRE Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021
09/07/2021 08:05 AM EDT ACCESSWIRE Hancock Jaffe Laboratories Announces $20 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules
08/19/2021 08:00 AM EDT ACCESSWIRE Hancock Jaffe Presents New Positive Two-Year VenoValve Data at the Society for Vascular Surgery Annual Meeting
08/03/2021 08:05 AM EDT ACCESSWIRE FDA Grants Breakthrough Device Designation Status for Hancock Jaffe's VenoValve
07/08/2021 09:05 AM EDT ACCESSWIRE Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference
05/10/2021 07:00 AM EDT GlobeNewswire CEO Presenting on the Emerging Growth Conference on May 12. Register here
04/23/2021 12:40 PM EDT ACCESSWIRE Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa Presents VenoValve One Year First-In-Human Data at Charing Cross International Symposium
Page